Company news

Jiangsu Kanion Pharmaceutical Co. Ltd. news in 2026

Jiangsu Kanion Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Reimbursement Drug List

November 15, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

November 2, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Report for Q3 2026

October 29, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Key Operating Data for the First Three Quarters of 2026

October 29, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Receipt of the Clinical Trial Approval Notice for Shiwei Anchang Granules

October 22, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Departure of Senior Executive

October 16, 2026

(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

October 9, 2026

Semi-annual Report for 2026

August 27, 2026

Announcement on Receipt of the Clinical Trial Approval Notice for Qihuang Zhengqi Granules

July 21, 2026

Announcement on Initially Repurchasing Shares through Call Auction

July 16, 2026

Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Essential Medicines List

July 9, 2026

Announcement on Progress in Repurchasing Shares through Call Auction

July 3, 2026

Announcement on Cancellation of Repurchased Shares and Notification to Creditors

June 26, 2026

Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit

June 22, 2026

Notice on Convening the 2025 Annual General Meeting

June 5, 2026

Report for Q1 2026

April 29, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

April 28, 2026

Announcement on Renewing Engagement of Accounting Firm

April 22, 2026

Announcement on Receiving the Clinical Trial Approval Notice for Qingshen Tongluo Granules

April 19, 2026

Announcement on Appointment of Deputy General Manager

March 30, 2026

Announcement on Receiving the Clinical Trial Approval Notice for Heihuang Chizhu Granules

February 25, 2026

Announcement on the Receipt of the Clinical Trial Approval Notice for Yunpi Huatan Tongqiao Granules

January 26, 2026

Announcement on the Receipt of the Clinical Trial Approval Notice for Plantago Seed Tablets

January 20, 2026